Asplenia Falsely Elevates HbA1c by Preventing Normal Hemoglobin Vesicle Removal
Asplenia causes falsely elevated HbA1c values because the spleen normally removes hemoglobin-containing vesicles from aging red blood cells, and without this "pitting" function, older glycated hemoglobin accumulates abnormally within circulating erythrocytes. 1
Mechanism of HbA1c Elevation in Asplenia
Normal Splenic Function and Hemoglobin Turnover
- The spleen facilitates removal of hemoglobin-containing vesicles from circulating red blood cells, a process called "pitting" that occurs predominantly in older RBCs during the second half of their lifespan. 1
- Approximately 20% of hemoglobin is normally lost from circulating RBCs through this vesiculation process, which the spleen actively removes. 1
What Happens Without a Spleen
- In asplenic individuals, hemoglobin-containing vesicles are retained within RBCs of all ages rather than being removed by splenic pitting. 1
- This vesicle retention leads to an increase in the percentage of total HbA1c because the glycated hemoglobin that would normally be removed remains in circulation. 1
- Old RBCs in asplenic patients show an increase in the absolute amount of HbA1c and HbA1e2, preventing the normal decrease in hemoglobin content per cell that occurs in individuals with intact spleens. 1
Clinical Implications
Interpretation Pitfalls
- Asplenia causes HbA1c to overestimate true glycemic control, potentially leading to undertreatment of diabetes or false-positive diabetes diagnoses in non-diabetic asplenic patients. 2, 3
- This effect is the opposite of conditions that shorten RBC lifespan (hemolytic anemia, acute blood loss), which falsely lower HbA1c by approximately 0.8–0.9%. 3
When to Suspect Falsely Elevated HbA1c
- Unexpectedly high HbA1c relative to self-monitoring blood glucose or continuous glucose monitoring results. 2
- Known asplenia (surgical splenectomy or functional asplenia from conditions like sickle cell disease). 1, 4, 5
Alternative Glycemic Markers for Asplenic Patients
Use fructosamine or glycated albumin instead of HbA1c in asplenic patients to accurately assess glycemic control. 3, 6
Why Alternative Markers Work Better
- Fructosamine and glycated albumin reflect average glycemia over 2–3 weeks and are completely unaffected by red blood cell turnover abnormalities or splenic function. 3, 6
- These markers showed no correlation with hemolytic markers (including reticulocytes, haptoglobin, and erythrocyte creatine) in research studies, whereas HbA1c showed significant correlations with all hemolytic markers. 6
- Glycated albumin and fructosamine accurately reflect glycemic control in patients with altered RBC lifespan, while HbA1c does not. 6
Common Pitfalls to Avoid
- Do not rely on HbA1c alone in patients with known or suspected asplenia—always correlate with direct glucose measurements or use alternative glycated protein assays. 3, 6
- Remember that functional asplenia develops progressively in certain hemoglobinopathies: it is rare before age 4 years in hemoglobin SC disease but occurs in 22% of patients aged 4–12 years and 45% of those over 12 years. 4
- Functional asplenia is an acquired defect in sickle cell disease, typically developing during the first year of life. 5